WCLC 2024 – Andrea R. Filippi
Andrea R. Filippi talks about optimizing radiation and chemotherapy or immunotherapy combinations to improve efficacy and reduce side effects in locally advanced lung cancer. He addresses biomarkers guiding treatment, the importance of timing and sequencing, and differences between chemotherapy, immunotherapy, and targeted therapies, while highlighting promising trials and advancements for aimed at improving survival rates and quality of life for patients.
Here is the full WCLC 2024 report.
More posts
Ovarian cancer: taking PARP inhibition one step further
Ovarian cancer: taking PARP inhibition one step further Individualized dosing o
Getting innovation from the laboratories into clinical practice
Getting innovation from the laboratories into clinical practice Andrés Cervantes
Milestones of PD-1 inhibition in gastric and esophageal cancer
Milestones of PD-1 inhibition in gastric and esophageal cancer Gastric cancer,
Preface – ESMO 2020 Solid Tumors
Preface – ESMO 2020 Solid Tumors Ronan Kelly, MD, MBA – Director of the